Stroke, Vol 22, 780-784, Copyright © 1991 by American Heart Association
Y Yamamoto, BR Clower, JL Haining and RR Smith
Recombinant tissue plasminogen activator may be effective in preventing
cerebral vasospasm after subarachnoid hemorrhage by resolving subarachnoid
clots. We previously demonstrated that blood placed on the adventitial
surface of cerebral arteries enhances intimal platelet accumulation,
positively correlating with endothelial damage and other pathologic changes
in vessel walls. In this study, we investigated the ability of a single
bolus injection of tissue plasminogen activator to prevent platelet
accumulation in cerebral vessels after subarachnoid hemorrhage.
Subarachnoid hemorrhage was produced in cats by the transorbital
intracisternal injection of 2.5 ml autologous arterial blood around the
proximal part of the right middle cerebral artery. In 10 animals, 25
micrograms tissue plasminogen activator was injected at intervals of 10
(five cats) and 60 minutes (five cats) after subarachnoid hemorrhage.
Intracisternal physiological saline (0.5 ml) was injected in six cats 10
minutes after subarachnoid hemorrhage. Platelets labeled with indium-111
were injected intravenously just before subarachnoid hemorrhage, and their
radioactivity was measured in cerebral arteries at death. The results
indicated that, after subarachnoid hemorrhage, early injection of tissue
plasminogen activator inhibited intimal platelet accumulation, but later
injection did not, although the extent of subarachnoid clot was reduced at
both plasminogen injection times.
ARTICLES
Effect of tissue plasminogen activator on intimal platelet accumulation in cerebral arteries after subarachnoid hemorrhage in cats
Department of Neurosurgery, University of Mississippi Medical Center, Jackson 39216-4505.
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |